↓ Skip to main content

Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration

Overview of attention for article published in International Journal of Nanomedicine, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#36 of 2,456)
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs
1 blog
twitter
4 tweeters

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
186 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
Published in
International Journal of Nanomedicine, June 2013
DOI 10.2147/ijn.s44393
Pubmed ID
Authors

Gu, Wu, Chen, Yin Xiao

Abstract

Nanotechnology is a vigorous research area and one of its important applications is in biomedical sciences. Among biomedical applications, targeted drug delivery is one of the most extensively studied subjects. Nanostructured particles and scaffolds have been widely studied for increasing treatment efficacy and specificity of present treatment approaches. Similarly, this technique has been used for treating bone diseases including bone regeneration. In this review, we have summarized and highlighted the recent advancement of nanostructured particles and scaffolds for the treatment of cancer bone metastasis, osteosarcoma, bone infections and inflammatory diseases, osteoarthritis, as well as for bone regeneration. Nanoparticles used to deliver deoxyribonucleic acid and ribonucleic acid molecules to specific bone sites for gene therapies are also included. The investigation of the implications of nanoparticles in bone diseases have just begun, and has already shown some promising potential. Further studies have to be conducted, aimed specifically at assessing targeted delivery and bioactive scaffolds to further improve their efficacy before they can be used clinically.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 2 1%
Turkey 1 <1%
Germany 1 <1%
South Africa 1 <1%
Unknown 181 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 44 24%
Researcher 28 15%
Student > Master 26 14%
Student > Bachelor 22 12%
Student > Doctoral Student 12 6%
Other 23 12%
Unknown 31 17%
Readers by discipline Count As %
Chemistry 25 13%
Agricultural and Biological Sciences 22 12%
Medicine and Dentistry 20 11%
Materials Science 18 10%
Pharmacology, Toxicology and Pharmaceutical Science 18 10%
Other 42 23%
Unknown 41 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2015.
All research outputs
#1,029,761
of 12,438,331 outputs
Outputs from International Journal of Nanomedicine
#36
of 2,456 outputs
Outputs of similar age
#14,192
of 148,291 outputs
Outputs of similar age from International Journal of Nanomedicine
#1
of 89 outputs
Altmetric has tracked 12,438,331 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,456 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,291 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.